175 related articles for article (PubMed ID: 10805280)
21. TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots.
Mutch NJ; Thomas L; Moore NR; Lisiak KM; Booth NA
J Thromb Haemost; 2007 Apr; 5(4):812-7. PubMed ID: 17388801
[TBL] [Abstract][Full Text] [Related]
22. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
23. The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1.
Whyte CS; Simpson M; Morrow GB; Wallace CA; Mentzer AJ; Knight JC; Shapiro S; Curry N; Bagot CN; Watson H; Cooper JG; Mutch NJ
J Thromb Haemost; 2022 Oct; 20(10):2394-2406. PubMed ID: 35780481
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.
Sakata Y; Loskutoff DJ; Gladson CL; Hekman CM; Griffin JH
Blood; 1986 Dec; 68(6):1218-23. PubMed ID: 3096399
[TBL] [Abstract][Full Text] [Related]
25. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
[TBL] [Abstract][Full Text] [Related]
26. Impaired clot lysis by rt-PA catalyzed mini-plasminogen activation.
Duboscq C; Genoud V; Parborell MF; Kordich LC
Thromb Res; 1997 Jun; 86(6):505-13. PubMed ID: 9219330
[TBL] [Abstract][Full Text] [Related]
27. Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat.
Reilly CF; Fujita T; Mayer EJ; Siegfried ME
Arterioscler Thromb; 1991; 11(5):1276-86. PubMed ID: 1911713
[TBL] [Abstract][Full Text] [Related]
28. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
Torr-Brown SR; Sobel BE
Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
[TBL] [Abstract][Full Text] [Related]
30. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
Talbot K; Meixner SC; Pryzdial EL
Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
[TBL] [Abstract][Full Text] [Related]
31. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
32. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
Szczepaniak P; Zabczyk M; Undas A
PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
[TBL] [Abstract][Full Text] [Related]
33. [Plasminogen activation and regulation of fibrinolysis].
Madoiwa S
Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
[TBL] [Abstract][Full Text] [Related]
34. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
Braaten JV; Handt S; Jerome WG; Kirkpatrick J; Lewis JC; Hantgan RR
Blood; 1993 Mar; 81(5):1290-9. PubMed ID: 8443390
[TBL] [Abstract][Full Text] [Related]
35. Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin.
Eriksson E; Wollter IM; Christenson B; Stigendal L; Risberg B
Thromb Haemost; 1988 Apr; 59(2):284-8. PubMed ID: 2838926
[TBL] [Abstract][Full Text] [Related]
36. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
37. Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.
Takada A; Takada Y; Urano T; Sakakibara K; Rydzewski A
Thromb Res; 1990 Jan; 57(1):13-20. PubMed ID: 2105539
[TBL] [Abstract][Full Text] [Related]
38. Coagulation and fibrinolytic responses of human peritoneal fluid and plasma to bacterial peritonitis.
van Goor H; Bom VJ; van der Meer J; Sluiter WJ; Bleichrodt RP
Br J Surg; 1996 Aug; 83(8):1133-5. PubMed ID: 8869327
[TBL] [Abstract][Full Text] [Related]
39. Fibrinolytic proteins in human bile accelerate lysis of plasma clots and induce breakdown of fibrin sealants.
Boonstra EA; Adelmeijer J; Verkade HJ; de Boer MT; Porte RJ; Lisman T
Ann Surg; 2012 Aug; 256(2):306-12. PubMed ID: 22797359
[TBL] [Abstract][Full Text] [Related]
40. The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha2-antiplasmin by reptilase, a thrombin-like venom enzyme.
Urano T; Ihara H; Takada Y; Fujie M; Takada A
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):145-53. PubMed ID: 10759007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
